SOT is a personalized therapy for viruses and pathogens including Lyme Disease. The SOT has the ability to bind to a specific gene of interest that controls the pathogen by disrupting the critical process that promotes its survival or growth. During this therapy, the patient’s blood is analyzed and a complementary oligonucleotide sequence is created that is designed to interrupt the survival or growth of the cells.